"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
- Patient Information:
Details with Side Effects
DOSAGE AND ADMINISTRATION
Anusol-HC 2.5% (Hydrocortisone Cream, USP) should be applied to the affected area two to four times daily depending on the severity of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
STORE AT 20°-25°C (68°-77°F). SEE USP CONTROLLED ROOM TEMPERATURE. STORE AWAY FROM HEAT. PROTECT FROM FREEZING.
PRESCRIBING INFORMATION AS OF OCTOBER 2003. Manufactured for: Salix Pharmaceuticals, Inc., Morrisville, NC 27560. FDA Rev date: 8/11/2000
Last reviewed on RxList: 1/4/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Anusol Hc Information
Anusol Hc - User Reviews
Anusol Hc User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.